VF
NMRA icon

Virtu Financial’s Neumora Therapeutics NMRA Stock Holding History

Virtu Financial’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$50K Sell
25,489
-71,919
-74% -$186K ﹤0.01% 1289
2025
Q4 		$174K Buy
97,408
+80,189
+466% +$176K 0.01% 1068
2025
Q3 		$31K Buy
+17,219
New +$27.8K ﹤0.01% 1223
2025
Q2 		– Sell
-39,676
Closed -$40K – 1856
2025
Q1 		$40K Buy
+39,676
New +$67.9K ﹤0.01% 1040

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $196M AUM 84.21% 1-Year Est. Return

Virtu Financial's NMRA Position: Q1 2026 in Review

Virtu Financial reduced its Neumora Therapeutics (NMRA) stake by 74% in Q1 2026, selling an estimated $186K and leaving 25,489 shares worth $50K. The position accounts for ﹤0.01% of the portfolio, ranked #1289.

Virtu Financial first reported a position in NMRA in Q1 2025 and has held it in 4 quarters since. The position peaked at $174K in Q4 2025. 114 funds tracked by Wall St. Rank hold NMRA as of Q1 2026.

  • Virtu Financial held 25,489 shares of Neumora Therapeutics worth $50K as of Q1 2026.
  • Virtu Financial sold 71,919 Neumora Therapeutics shares in Q1 2026, an estimated $186K.
  • Neumora Therapeutics made up ﹤0.01% of Virtu Financial's portfolio in Q1 2026, its #1289 holding.
  • Virtu Financial first reported a position in Neumora Therapeutics in Q1 2025 and has held it in 4 quarters since.
  • Virtu Financial's Neumora Therapeutics position peaked at $174K in Q4 2025.
  • 114 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.